Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease.

[1]  S. Bailey,et al.  A prospective multicenter registry of laser therapy for degenerated saphenous vein graft stenosis: the COronary graft Results following Atherectomy with Laser (CORAL) trial. , 2012, Cardiovascular revascularization medicine : including molecular interventions.

[2]  A. M. Leone,et al.  Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[3]  K. Kent,et al.  Outcomes of patients with acute myocardial infarction rom a saphenous vein graft culprit undergoing percutaneous coronary intervention , 2011, Catheterization and cardiovascular interventions.

[4]  G. Niccoli,et al.  Laser for complex coronary lesions: impact of excimer lasers and technical advancements. , 2011, International journal of cardiology.

[5]  Volkmar Falk,et al.  Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[6]  E. Picano,et al.  Excimer laser in acute myocardial infarction: single centre experience on 66 patients. , 2008, International journal of cardiology.

[7]  A. J. O’Malley,et al.  Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients , 2008, Circulation.

[8]  C. Rogers,et al.  The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. , 2007, Journal of the American College of Cardiology.

[9]  S. Dixon,et al.  Embolic protection of saphenous vein graft percutaneous interventions. , 2007, Journal of interventional cardiology.

[10]  G. Stone,et al.  Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial. , 2006, American heart journal.

[11]  F. Burzotta,et al.  Filter no reflow during percutaneous coronary interventions using the Filterwire distal protection device. , 2004, International journal of cardiology.

[12]  C. Rogers,et al.  Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries. , 2005, The American journal of cardiology.

[13]  D. Holmes,et al.  Applicability of distal protection for aortocoronary vein graft interventions in clinical practice , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  E. Antman,et al.  Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. , 2004, American heart journal.

[15]  E. Alderman,et al.  Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction. , 2004, The Journal of invasive cardiology.

[16]  I. Porto,et al.  Debris Trapped by a Distal Protection Device May Mimic No-Reflow During Percutaneous Coronary Intervention , 2004 .

[17]  J. Garasic Textbook of interventional cardiology; 4th edition: Eric J. Topol, MD; Philadelphia; 2003; Saunders; 1123 pages; $185.00 , 2003 .

[18]  G. Stone,et al.  Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts , 2003, Circulation.

[19]  G. Stone,et al.  Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. , 2002, Journal of the American College of Cardiology.

[20]  M. Leon,et al.  Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.

[21]  M. Carr,et al.  Alterations of Platelet Aggregation Kinetics with Ultraviolet Laser Emission: The “Stunned Platelet” Phenomenon , 2001, Thrombosis and Haemostasis.

[22]  W. O’Neill,et al.  Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. , 2001, Journal of the American College of Cardiology.

[23]  E. Antman,et al.  Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction: A TIMI 14 Substudy , 2001, Circulation.

[24]  P. Teirstein,et al.  Retrieval and analysis of particulate debris after saphenous vein graft intervention. , 1999, Journal of the American College of Cardiology.

[25]  H. Suryapranata,et al.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. , 1998, Circulation.

[26]  A. Baumbach,et al.  Perspectives of coronary excimer laser angioplasty: Multiplexing, saline flushing, and acoustic ablation control , 1997, Lasers in surgery and medicine.

[27]  W J Keon,et al.  Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.

[28]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[29]  M. Cleman,et al.  Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators. , 1995, Circulation.

[30]  R. Califf,et al.  A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. , 1995, Circulation.

[31]  B. Strauss,et al.  Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. , 1994, The American journal of cardiology.

[32]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.